In vitro hemolytic performance of the Realheart®V11C TAHprototype with porcine blood
Artificial Organs2023Vol. 47(7), pp. 1208–1213
Citations Over Time
Ina Laura Perkins, Eva Maria Mansisidor, Shaikh Faisal Zaman, Kyle R. Mudge, Owen Bodger, Azad Najar
Abstract
The absolute and the relative hemolysis of the V11C are lower compared to both the large and small Reinheart TAH devices published values. Pulsatile pumps create more hemolysis in the Aachen rig, and it is not known if this is because how the rig handles pulsatile flow or due to the devices. Future studies will, therefore, use a pulsatile pump such as the SynCardia as clinical comparator and human blood to test the performance of future Realheart TAH prototypes.
Related Papers
- → Pulsatile vs. continuous flow in ventricular assist device therapy(2012)39 cited
- → Effect of intracardiac blood flow pulsatility during radiofrequency cardiac ablation: computer modeling study(2021)10 cited
- → In vitro hemolytic performance of the Realheart®V11C TAHprototype with porcine blood(2023)2 cited
- → 139: Reducing Adverse Neurological Events in LVAD Patients: Pulsatile vs. Continuous Flow?(2010)
- → Gene Expression in Pediatric Myocardium: Pulsatile- vs. Continuous-Flow VAD Support(2017)